Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations

Lupus

Volumn 22, Issue 8, 2013, Pages 855-864

  Rangel, M L ^a   Alghamdi, I ^a   Contreras, G ^a   Harrington, T ^a   Thomas, D B ^a   Barisoni, L ^a   Andrews, D ^a   Wolf, M ^a   Asif, A ^b   Nayer, A ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

CAPS; Catastrophic antiphospholipid syndrome; diffuse alveolar hemorrhage; glucocorticoids; hemorrhage; interstitial hemorrhage; plasma exchange; plasmapheresis; thrombotic microangiopathy

Indexed keywords

ALBUMIN; ATENOLOL; BETA2 GLYCOPROTEIN 1 ANTIBODY; C REACTIVE PROTEIN; CAPTOPRIL; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C4; CRYOGLOBULIN; FRESH FROZEN PLASMA; GLUCOCORTICOID; HAPTOGLOBIN; IBUPROFEN; LACTATE DEHYDROGENASE; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; POTASSIUM; PREDNISONE; PROTHROMBIN ANTIBODY;

ABDOMINAL PAIN; ABNORMAL LABORATORY RESULT; ACUTE GASTROENTERITIS; ACUTE KIDNEY FAILURE; ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRONCHOSCOPY; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COMPLEMENT BLOOD LEVEL; CORONARY ARTERY DISEASE; COUGHING; DEHYDRATION; DIABETES MELLITUS; DIARRHEA; DIPLOPIA; DRUG MEGADOSE; DYSPNEA; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FAMILY HISTORY; FEMALE; FINGER AMPUTATION; FLUID THERAPY; GANGRENE; HEADACHE; HEMATURIA; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; HYPOKALEMIA; INTERACTIVE VENTILATORY SUPPORT; KIDNEY BIOPSY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION TEST; LUNG HEMORRHAGE; LUNG INFILTRATE; LUNG LAVAGE; LYMPHADENOPATHY; MEDICAL HISTORY; NAUSEA; NORMOCHROMIC NORMOCYTIC ANEMIA; OBESITY; OXYGEN SUPPLY; PARTIAL THROMBOPLASTIN TIME; PATIENT REFERRAL; PLASMAPHERESIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; PROTHROMBIN TIME; RARE DISEASE; RESPIRATORY FAILURE; SEROLOGY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERMINAL DISEASE; THORAX PAIN; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TOE GANGRENE; URINALYSIS; VOMITING;

CAPS; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; DIFFUSE ALVEOLAR HEMORRHAGE; GLUCOCORTICOIDS; HEMORRHAGE; INTERSTITIAL HEMORRHAGE; PLASMA EXCHANGE; PLASMAPHERESIS; THROMBOTIC MICROANGIOPATHY;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HEMORRHAGE; HUMANS; PLASMA EXCHANGE; PULMONARY ALVEOLI; RESPIRATORY INSUFFICIENCY; THROMBOSIS;

EID: 84879733240     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313491024     Document Type: Article

References (24)

1. Hughes GR. Hughes Syndrome (the antiphospholipid syndrome): Ten clinical lessons. Autoimmun Rev. 2008 ; 7: 262-266
2. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore). 1998 ; 77: 195-207
3. Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus. 2003 ; 12: 530-534
4. Cervera R, Bucciarelli S, Plasín MA, et al. Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the "CAPS Registry''. J Autoimmun. 2009 ; 32: 240-245
5. Asherson RA, Cervera R. Catastrophic antiphospholipid syndrome. Curr Opin Hematol. 2000 ; 7: 325-329
6. Asherson RA, Espinosa G, Cervera R, Font J, Reverter JC. Catastrophic antiphospholipid syndrome: Proposed guidelines for diagnosis and treatment. J Clin Rheumatol. 2002 ; 8: 157-165
7. Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum. 2000 ; 43: 440-443
8. Asherson RA. The catastrophic antiphospholipid (Asherson's) syndrome in 2004 - a review. Autoimmun Rev. 2005 ; 4: 48-54
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
10. Espinosa G, Cervera R, Font J, Asherson RA. The lung in the antiphospholipid syndrome. Ann Rheum Dis. 2002 ; 61: 195-198
11. Salmon JE, de Groot PG. Pathogenic role of antiphospholipid antibodies. Lupus. 2008 ; 17: 405-411
12. Tektonidou MG, Sotsiou F, Moutsopoulos HM. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. J Rheumatol. 2008 ; 35: 1983-1988
13. Moll S, Kudrik FJ, Thomas DB. Catastrophic antiphospholipid antibody syndrome. Am J Hematol. 2003 ; 72: 278-279
14. Forastiero R. Bleeding in the antiphospholipid syndrome. Hematology. 2012 ; 17: S153 - S155
15. Forastiero R, Martinuzzo M, Pombo G, et al. A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis. J Thromb Haemost. 2005 ; 3: 1231-1238
16. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002 ; 347: 589-600
17. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999 ; 341: 586-592
18. Kelton JG, Arnold DM, Bates SM. Nonheparin anticoagulants for heparin-induced thrombocytopenia. N Engl J Med. 2013 ; 368: 737-744
19. Warkentin TE, Makris M, Jay RM, Kelton JG. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia. Am J Med. 2008 ; 121: 632-636
20. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest. 1992 ; 101: 1644-1655
21. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999 ; 340: 448-454
22. Erkan D, Lockshin MD. New approaches for managing antiphospholipid syndrome. Nat Clin Pract Rheumatol. 2009 ; 5: 160-170
23. Walport MJ. Complement. First of two parts. N Engl J Med. 2001 ; 344: 1058-1066
24. Bucciarelli S, Espinosa G, Cervera R, et al. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 2006 ; 54: 2568-2576